{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T04:02:25Z","timestamp":1767067345989,"version":"3.48.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05394-0","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:37:10Z","timestamp":1764250630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of carperitide on clinical outcomes among patients with acute heart failure: a meta-analysis of randomized and propensity\u2011matched studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Tsuyoshi","family":"Shiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachie","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"5394_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/01.CIR.76.1.115","volume":"76","author":"Y Saito","year":"1987","unstructured":"Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 1987;76(1):115\u201324.","journal-title":"Circulation"},{"issue":"10","key":"5394_CR2","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","volume":"83","author":"H Tsutsui","year":"2019","unstructured":"Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart Failure\u3000- digest version. Circ J. 2019;83(10):2084\u2013184.","journal-title":"Circ J"},{"issue":"6","key":"5394_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ahj.2010.03.019","volume":"159","author":"N Sato","year":"2010","unstructured":"Sato N, Kajimoto K, Asai K, Mizuno M, Minami Y, Nagashima M, et al. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J. 2010;159(6):949\u201355. e1.","journal-title":"Am Heart J"},{"issue":"2","key":"5394_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jjcc.2013.03.009","volume":"62","author":"S Hamaguchi","year":"2013","unstructured":"Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, et al. Characteristics, management, and outcomes for patients during hospitalization due to worsening heart failure-A report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). J Cardiol. 2013;62(2):95\u2013101.","journal-title":"J Cardiol"},{"issue":"18","key":"5394_CR5","doi-asserted-by":"publisher","first-page":"e008687","DOI":"10.1161\/JAHA.118.008687","volume":"7","author":"Y Shiraishi","year":"2018","unstructured":"Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9-Year trend in the management of acute heart failure in japan: A report from the National consortium of acute heart failure registries. J Am Heart Assoc. 2018;7(18):e008687.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"5394_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ehf2.12418","volume":"6","author":"T Shiga","year":"2019","unstructured":"Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, et al. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. 2019;6(3):475\u201386.","journal-title":"ESC Heart Fail"},{"issue":"8","key":"5394_CR7","first-page":"2602","volume":"70","author":"M Iizuka","year":"1993","unstructured":"Iizuka M, Sugimoto T, Yasuda H, Imura H, Kawai C, Obata H, et al. Evaluation of the clinical utility of carperitide (SUN 4936) for acute heart failure - A randomized, double-blind, placebo-controlled, multicenter study-. Japanese J Clin Experimental Med. 1993;70(8):2602\u201317. (in Japanese).","journal-title":"Japanese J Clin Experimental Med"},{"issue":"6","key":"5394_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/00005344-199906000-00016","volume":"33","author":"S Kitashiro","year":"1999","unstructured":"Kitashiro S, Sugiura T, Takayama Y, Tsuka Y, Izuoka T, Tokunaga S, et al. Long-term administration of atrial natriuretic peptide in patients with acute heart failure. J Cardiovasc Pharmacol. 1999;33(6):948\u201352.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"5394_CR9","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","volume":"72","author":"N Hata","year":"2008","unstructured":"Hata N, Seino Y, Tsutamoto T, Hiramitsu S, Kaneko N, Yoshikawa T, et al. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. Circ J. 2008;72(11):1787\u201393.","journal-title":"Circ J"},{"issue":"5","key":"5394_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cardfail.2023.02.009","volume":"29","author":"H Tsutsui","year":"2023","unstructured":"Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, et al. Natriuretic peptides: role in the diagnosis and management of heart failure: A scientific statement from the heart failure association of the European society of Cardiology, heart failure society of America and Japanese heart failure society. J Card Fail. 2023;29(5):787\u2013804.","journal-title":"J Card Fail"},{"issue":"2","key":"5394_CR11","first-page":"83","volume":"14","author":"S Honda","year":"2025","unstructured":"Honda S, Nagai T, Honda Y, Nakano H, Kawabata T, Maeda H, et al. Effect of Low-dose administration of carperitide for acute heart failure: the LASCAR-AHF trial. Eur Heart J Acute Cardiovasc Care. 2025;14(2):83\u201392.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"8","key":"5394_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1253\/circj.CJ-25-0002","volume":"89","author":"T Kitai","year":"2025","unstructured":"Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, et al. JCS\/JHFS 2025 guideline on diagnosis and treatment of heart failure. Circ J. 2025;89(8):1278\u2013444.","journal-title":"Circ J"},{"issue":"1","key":"5394_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/sim.2739","volume":"26","author":"DB Rubin","year":"2007","unstructured":"Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med. 2007;26(1):20\u201336.","journal-title":"Stat Med"},{"key":"5394_CR14","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.","journal-title":"BMJ"},{"key":"5394_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"5394_CR16","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"issue":"11","key":"5394_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.cardfail.2015.05.007","volume":"21","author":"Y Matsue","year":"2015","unstructured":"Matsue Y, Kagiyama N, Yoshida K, Kume T, Okura H, Suzuki M, et al. Carperitide is associated with increased In-Hospital mortality in acute heart failure: A propensity Score-Matched analysis. J Card Fail. 2015;21(11):859\u201364.","journal-title":"J Card Fail"},{"issue":"8","key":"5394_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00380-017-0952-0","volume":"32","author":"M Ogiso","year":"2017","unstructured":"Ogiso M, Isogai T, Okabe Y, Ito K, Tsuji M, Tanaka H. Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses. Heart Vessels. 2017;32(8):916\u201325.","journal-title":"Heart Vessels"},{"key":"5394_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijcard.2017.04.078","volume":"241","author":"A Mizuno","year":"2017","unstructured":"Mizuno A, Iguchi H, Sawada Y, Hurley M, Nomura H, Hayashi K, et al. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute heart failure: high value care vs. low value care campaign in Japan. Int J Cardiol. 2017;241:243\u20138.","journal-title":"Int J Cardiol"},{"key":"5394_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijcard.2019.01.049","volume":"280","author":"T Nagai","year":"2019","unstructured":"Nagai T, Iwakami N, Nakai M, Nishimura K, Sumita Y, Mizuno A, et al. Effect of intravenous carperitide versus nitrates as first-line vasodilators on in-hospital outcomes in hospitalized patients with acute heart failure: insight from a nationwide claim-based database. Int J Cardiol. 2019;280:104\u20139.","journal-title":"Int J Cardiol"},{"issue":"2","key":"5394_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3999\/jscpt.56.2_63","volume":"56","author":"A Suzuki","year":"2025","unstructured":"Suzuki A, Shiga T. HIJ-HF II investigators. Effect of carperitide on clinical outcomes in patients with acute decompensated heart failure: A subanalysis of the HIJ-HF II study. Jpn J Clin Pharmacol Ther. 2025;56(2):63\u201370.","journal-title":"Jpn J Clin Pharmacol Ther"},{"issue":"5\u20136","key":"5394_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10557-017-6760-z","volume":"31","author":"T Nagai","year":"2017","unstructured":"Nagai T, Honda Y, Nakano H, Honda S, Iwakami N, Mizuno A, et al. Rationale and design of Low-dose administration of carperitide for acute heart failure (LASCAR-AHF). Cardiovasc Drugs Ther. 2017;31(5\u20136):551\u20137.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"5394_CR23","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/ejhf.609","volume":"18","author":"K Damman","year":"2016","unstructured":"Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, et al. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. Eur J Heart Fail. 2016;18(12):1508\u201317.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"5394_CR24","doi-asserted-by":"publisher","first-page":"e007910","DOI":"10.1161\/JAHA.117.007910","volume":"7","author":"J Kang","year":"2018","unstructured":"Kang J, Park JJ, Cho YJ, Oh IY, Park HA, Lee SE, et al. Predictors and prognostic value of worsening renal function during admission in HFpEF versus hfref: data from the KorAHF (Korean acute heart Failure) registry. J Am Heart Assoc. 2018;7(6):e007910.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"5394_CR25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","volume":"111","author":"JD Sackner-Bernstein","year":"2005","unstructured":"Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111(12):1487\u201391.","journal-title":"Circulation"},{"issue":"15","key":"5394_CR26","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","volume":"293","author":"JD Sackner-Bernstein","year":"2005","unstructured":"Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA. 2005;293(15):1900\u20135.","journal-title":"JAMA"},{"issue":"9","key":"5394_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/eurjhf\/hfr060","volume":"13","author":"AA Voors","year":"2011","unstructured":"Voors AA, Davison BA, Felker GM, Ponikowski P, Unemori E, Cotter G, et al. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. Eur J Heart Fail. 2011;13(9):961\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"5394_CR28","doi-asserted-by":"publisher","first-page":"e008545","DOI":"10.1136\/bmjopen-2015-008545","volume":"6","author":"B Gong","year":"2016","unstructured":"Gong B, Wu Z, Li Z. Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials. BMJ Open. 2016;6(1):e008545.","journal-title":"BMJ Open"},{"issue":"2","key":"5394_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/ehf2.13770","volume":"9","author":"K Nogi","year":"2022","unstructured":"Nogi K, Ueda T, Matsue Y, Ishihara S, Nakada Y, Kawakami R, et al. Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure. ESC Heart Fail. 2022;9(2):1061\u201370.","journal-title":"ESC Heart Fail"},{"issue":"5","key":"5394_CR30","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41440-022-00888-2","volume":"45","author":"T Tsuchihashi","year":"2022","unstructured":"Tsuchihashi T. Dietary salt intake in Japan - past, present, and future. Hypertens Res. 2022;45(5):748\u201357.","journal-title":"Hypertens Res"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05394-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05394-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:34:03Z","timestamp":1767065643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05394-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5394"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05394-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Tsuyoshi Shiga has received lecture fees from AstraZeneca, Bristol-Myers Squibb, and Daichi-Sankyo and has received grant support from Ono Pharmaceutical. The others have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"896"}}